High-Flying Biotech Stock 360% Faces Trim, Top Holding
A biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
Compare 2024 dividend aristocrats ETF fees to find the lowest cost option. This guide highlights expense ratios and what to look for in a low-cost fund.
27,654 articlesA biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
Cambridge Mobile Telematics has raised $350 million in a strategic round led by TPG Rise Funds and Allianz X, with St...
Visa has won approval to join the Canton Network as its top Super Validator. The move signals deeper enterprise parti...
Oil trading desks warn that disruptions through the Strait of Hormuz could trigger a global crude supply squeeze as A...
Coinbase announced a restructuring that will cut roughly 700 positions, or 14% of its workforce, citing crypto market...
A SpaceX IPO could reshape growth investing, creating upside for Rivian and other high-growth names. This guide break...
Howard Lindzon’s work with StockTwits and Social Leverage reshapes how we think about investing in communities. This ...
Peloton has faced a brutal selloff, but the story isn’t finished. This article dives into whether Peloton is broken o...
Analysts are signaling a higher cost-of-living adjustment for 2027 as inflation persists, with estimates pointing to ...
A major portfolio move by Deepwater Asset Management shaved nearly half of its stake in Global-E Online. Here’s what ...
U.S. healthcare equities rise as firms deploy agentic AI to cut labor costs, lifting a group of AI-enabled healthcare...
As AI and HPC demand accelerates, investors are shifting away from Intel toward foundry and lithography peers. This p...